Literature DB >> 12407022

Aging and developmental transitions in the B cell lineage.

Kara M Johnson1, Kevin Owen, Pamela L Witte.   

Abstract

One explanation for the deterioration of the humoral immune response in elderly individuals is that B lymphopoiesis declines with increasing age. Recent studies report a dramatic decline in pre-B cell numbers in old mice. Surprisingly, the number of mature B cells does not decline with age. To determine if new B cells are made in aged animals despite the drop in pre-B cells, we used 5'-bromo-2-deoxyuridine labeling to determine the production rate of B cells in the bone marrow and spleen of young and old mice. Because of the great variability in the number of early B lineage cells in old mice, we acquired data on >60 young and 50 old mice throughout these experiments. The transitional and mature B cell compartments in the spleen have slower labeling kinetics in old mice as compared to young. By the end of 4 weeks of labeling, an average of only 15% of the mature B cell compartment consists of newly made cells compared to 30% in young mice. However, in contrast to an earlier report, our results indicate that there is no statistical difference in the rate of production of new immature B cells in the marrow of young and old animals. In total, our results confirm previous work showing that mature B cells in old mice have a slower turnover, but more importantly suggest that the defect in mature B cell turnover is not due to a decline in B lymphopoiesis, but rather an inability of the newly made cells to replenish the peripheral compartments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12407022     DOI: 10.1093/intimm/dxf092

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  43 in total

Review 1.  Aging, B lymphopoiesis, and patterns of leukemogenesis.

Authors:  Robert A J Signer; Encarnacion Montecino-Rodriguez; Kenneth Dorshkind
Journal:  Exp Gerontol       Date:  2006-12-20       Impact factor: 4.032

Review 2.  Immunosenescence of ageing.

Authors:  A L Gruver; L L Hudson; G D Sempowski
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

3.  Aging and estrogen: modulation of inflammatory responses after injury.

Authors:  Christian R Gomez; Timothy P Plackett; Elizabeth J Kovacs
Journal:  Exp Gerontol       Date:  2007-01-03       Impact factor: 4.032

4.  Old mice retain bone marrow B1 progenitors, but lose B2 precursors, and exhibit altered immature B cell phenotype and light chain usage.

Authors:  Sarah Alter-Wolf; Bonnie B Blomberg; Richard L Riley
Journal:  Mech Ageing Dev       Date:  2009-04-09       Impact factor: 5.432

Review 5.  The ageing immune system: is it ever too old to become young again?

Authors:  Kenneth Dorshkind; Encarnacion Montecino-Rodriguez; Robert A J Signer
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

6.  Acquired hematopoietic stem cell defects determine B-cell repertoire changes associated with aging.

Authors:  Lisa M Guerrettaz; Sara A Johnson; John C Cambier
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-12       Impact factor: 11.205

Review 7.  Impaired B lymphopoiesis in old age: a role for inflammatory B cells?

Authors:  Richard L Riley
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 8.  Inflammatory immune cells may impair the preBCR checkpoint, reduce new B cell production, and alter the antibody repertoire in old age.

Authors:  Richard L Riley; Kelly Khomtchouk; Bonnie B Blomberg
Journal:  Exp Gerontol       Date:  2018-02-07       Impact factor: 4.032

9.  Migration of immature and mature B cells in the aged microenvironment.

Authors:  Heather A Minges Wols; Kara M Johnson; Jill A Ippolito; Shirin Z Birjandi; Yan Su; Phong T Le; Pamela L Witte
Journal:  Immunology       Date:  2009-10-21       Impact factor: 7.397

10.  A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice.

Authors:  Yi Hao; Patrick O'Neill; Martin S Naradikian; Jean L Scholz; Michael P Cancro
Journal:  Blood       Date:  2011-05-11       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.